Join to view full profile
5090 N 40th StSte 250Phoenix, AZ 85018
Phone+1 602-258-3354
Dr. Levine is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 1994 - 1997- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1993 - 1994
Duke University School of MedicineClass of 1993
Certifications & Licensure
IL State Medical License 2023 - 2029
NM State Medical License 2025 - 2029
WV State Medical License 2023 - 2028
WA State Medical License 2023 - 2028
TN State Medical License 2023 - 2028
ME State Medical License 2023 - 2028
FL State Medical License 2026 - 2028
American Board of Psychiatry and Neurology Neurology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Greenway Intergy Meaningful Use Edition, Greenway Health, LLC, 2017
- Top Doctors:Arizona State Castle Connolly, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
Publications & Presentations
PubMed
- A Practical Guide to Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.Johannes Jakobsen, Chafic Karam, Krista Kuitwaard, Todd Levine
Neurology and Therapy. 2026-10-01 - 5 citationsEfficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial.Tuan Vu, Ali A Habib, Saiju Jacob, Renato Mantegazza, Hiroyuki Murai
Lancet. 2026-05-02 - ALSUntangled #81: Pyridostigmine (mestinon).Nadia Mansoor, Terry Heiman-Patterson, Eva L Feldman, Paul Wicks, Michael Benatar
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2026-05-01
Press Mentions
CND Life Sciences Announces NIH Grant to Study the Risk of Parkinson's Disease in Patients with Essential TremorOctober 22nd, 2025- CND Life Sciences Is Granted FDA Breakthrough Device Designation for Its Skin Biopsy-Based Syn-One Test®October 7th, 2025
- Skin Biopsy Detects Neurodegenerative Biomarker in Idiopathic REM Sleep DisorderJune 11th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: